Caption Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-25,000
| Closed | -$228K | – | 1995 |
|
|
2025
Q2 | $228K | Hold |
25,000
| – | – | ﹤0.01% | 1243 |
|
|
2025
Q1 | $199K | Buy |
+25,000
| New | +$183K | ﹤0.01% | 1273 |
|
|
2024
Q4 | – | Sell |
-5,400
| Closed | -$39K | – | 1789 |
|
|
2024
Q3 | $39K | Hold |
5,400
| – | – | ﹤0.01% | 1178 |
|
|
2024
Q2 | $58.6K | Sell |
5,400
-24,600
| -82% | -$315K | ﹤0.01% | 1050 |
|
|
2024
Q1 | $562K | Buy |
+30,000
| New | +$692K | 0.01% | 853 |
|
|
2023
Q3 | – | Sell |
-60,000
| Closed | -$2.82M | – | 1516 |
|
|
2023
Q2 | $2.82M | Buy |
60,000
+30,000
| +100% | +$1.49M | 0.05% | 418 |
|
|
2023
Q1 | $1.26M | Buy |
+30,000
| New | +$1.29M | 0.02% | 575 |
|
|
2022
Q3 | – | Sell |
-22,500
| Closed | -$727K | – | 1803 |
|
|
2022
Q2 | $727K | Sell |
22,500
-97,900
| -81% | -$3.28M | 0.01% | 984 |
|
|
2022
Q1 | $3.99M | Buy |
120,400
+94,400
| +363% | +$3.55M | 0.05% | 512 |
|
|
2021
Q4 | $1.1M | Sell |
26,000
-14,000
| -35% | -$586K | 0.01% | 1012 |
|
|
2021
Q3 | $1.77M | Sell |
40,000
-282,700
| -88% | -$13M | 0.02% | 812 |
|
|
2021
Q2 | $18.3M | Buy |
322,700
+307,700
| +2,051% | +$21.8M | 0.24% | 95 |
|
|
2021
Q1 | $1.12M | Buy |
+15,000
| New | +$1.23M | 0.02% | 658 |
|
|
2020
Q1 | – | Sell |
-142,300
| Closed | -$10.3M | – | 1048 |
|
|
2019
Q4 | $10.3M | Buy |
142,300
+96,800
| +213% | +$11.9M | 0.35% | 61 |
|
|
2019
Q3 | $6.38M | Buy |
45,500
+8,000
| +21% | +$1.34M | 0.33% | 82 |
|
|
2019
Q2 | $6.87M | Buy |
37,500
+5,500
| +17% | +$938K | 0.35% | 81 |
|
|
2019
Q1 | $5.09M | Sell |
32,000
-15,000
| -32% | -$2.17M | 0.28% | 108 |
|
|
2018
Q4 | $4.5M | Buy |
+47,000
| New | +$5.38M | 0.36% | 87 |
|
Other funds holding SAGE
IA
HNB
Caption Management's SAGE Position: Q4 2024 in Review
Caption Management sold out of Sage Therapeutics (SAGE) in Q4 2024, closing a stake of 500 shares — an estimated $3.06K sold.
Caption Management first reported a position in SAGE in Q4 2018 and held it in 13 quarters. The position peaked at $7.93M in Q2 2021. 176 funds tracked by Wall St. Rank hold SAGE as of Q4 2024.
- Caption Management reported no remaining Sage Therapeutics position as of Q4 2024 after selling out during the quarter.
- Caption Management sold 500 Sage Therapeutics shares in Q4 2024, an estimated $3.06K.
- Caption Management first reported a position in Sage Therapeutics in Q4 2018 and held it in 13 quarters.
- Caption Management's Sage Therapeutics position peaked at $7.93M in Q2 2021.
- 176 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2024.
Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.